Trial · NCT04440592
Results by group56
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 56
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| The ACR CRISS Composite Score (0-1) at Week 52 | MT-7117 | 0.8537 | Full Range 0.000 to 1.000 | scores on ascale | |
| The ACR CRISS Composite Score (0-1) at Week 52 | Placebo | 0.8502 | Full Range 0.000 to 1.000 | scores on ascale | |
| Change in Health Assessment Questionnaire Disability Index (HAQ-DI) From Baseline up to Week 52 | MT-7117 | Change from baseline (BL) at Week 16 | -0.1439 | Standard Deviation 0.3803 | score on a scale |
| Change in Health Assessment Questionnaire Disability Index (HAQ-DI) From Baseline up to Week 52 | Placebo | Change from baseline (BL) at Week 16 | -0.0395 | Standard Deviation 0.3900 | score on a scale |
| Change in Health Assessment Questionnaire Disability Index (HAQ-DI) From Baseline up to Week 52 | MT-7117 | Change from BL at Week 26 | -0.0847 | Standard Deviation 0.3360 | score on a scale |
| Change in Health Assessment Questionnaire Disability Index (HAQ-DI) From Baseline up to Week 52 | Placebo | Change from BL at Week 26 | -0.0691 | Standard Deviation 0.4481 | score on a scale |
| Change in Health Assessment Questionnaire Disability Index (HAQ-DI) From Baseline up to Week 52 | MT-7117 | Change from BL at Week 39 | -0.0927 | Standard Deviation 0.3178 | score on a scale |
| Change in Health Assessment Questionnaire Disability Index (HAQ-DI) From Baseline up to Week 52 | Placebo | Change from BL at Week 39 | -0.0439 | Standard Deviation 0.5147 | score on a scale |
| Change in Health Assessment Questionnaire Disability Index (HAQ-DI) From Baseline up to Week 52 | MT-7117 | Change from BL at Week 52 | -0.1111 | Standard Deviation 0.4265 | score on a scale |
| Change in Health Assessment Questionnaire Disability Index (HAQ-DI) From Baseline up to Week 52 | Placebo | Change from BL at Week 52 | -0.0208 | Standard Deviation 0.5102 | score on a scale |
| Change in Percent Predicted Forced Vital Capacity (%pFVC) From Baseline up to Week 52 | MT-7117 | Change from BL at Week 16 | 0.754 | Standard Deviation 4.938 | %pFVC |
| Change in Percent Predicted Forced Vital Capacity (%pFVC) From Baseline up to Week 52 | Placebo | Change from BL at Week 16 | -1.058 | Standard Deviation 5.749 | %pFVC |
| Change in Percent Predicted Forced Vital Capacity (%pFVC) From Baseline up to Week 52 | MT-7117 | Change from BL at Week 26 | 0.904 | Standard Deviation 5.669 | %pFVC |
| Change in Percent Predicted Forced Vital Capacity (%pFVC) From Baseline up to Week 52 | Placebo | Change from BL at Week 26 | -0.691 | Standard Deviation 5.847 | %pFVC |
| Change in Percent Predicted Forced Vital Capacity (%pFVC) From Baseline up to Week 52 | MT-7117 | Change from BL at Week 39 | -1.201 | Standard Deviation 6.293 | %pFVC |
| Change in Percent Predicted Forced Vital Capacity (%pFVC) From Baseline up to Week 52 | Placebo | Change from BL at Week 39 | -1.457 | Standard Deviation 5.600 | %pFVC |
| Change in Percent Predicted Forced Vital Capacity (%pFVC) From Baseline up to Week 52 | MT-7117 | Change from BL at Week 52 | 0.048 | Standard Deviation 6.917 | %pFVC |
| Change in Percent Predicted Forced Vital Capacity (%pFVC) From Baseline up to Week 52 | Placebo | Change from BL at Week 52 | -2.906 | Standard Deviation 5.101 | %pFVC |
| Change in Patient Global Assessment From Baseline up to Week 52 | MT-7117 | Change from BL at Week 16 | -0.8 | Standard Deviation 1.8 | score on a scale |
| Change in Patient Global Assessment From Baseline up to Week 52 | Placebo | Change from BL at Week 16 | -0.3 | Standard Deviation 1.9 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04440592/results